ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals
- 22 February 2024
- journal article
- research article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 23 (3) , 388-397
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Carrier screening for cystic fibrosis in the new era of medications that restore CFTR functionThe Lancet, 2014
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutationNew England Journal of Medicine, 2011
- Recommendations for the classification of diseases as CFTR-related disordersJournal of Cystic Fibrosis, 2011
- Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic FibrosisThe Journal of Pediatrics, 2009
- Inconclusive Cystic Fibrosis neonatal screening results: long‐term psychosocial effects on parentsActa Paediatrica, 2009
- Cystic Fibrosis: Lessons from the Sweat GlandPhysiology, 2007
- Mutations in the Cystic Fibrosis Transmembrane Regulator Gene and In Vivo Transepithelial PotentialsAmerican Journal of Respiratory and Critical Care Medicine, 2006
- The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitisHuman Genetics, 2005
- Cystic fibrosis carriers have higher neonatal immunoreactive trypsinogen values than non‐carriersAmerican Journal of Medical Genetics Part A, 2005
- Abnormal frequency of ΔF508 mutation in neonatal transitory hypertrypsinaemiaThe Lancet, 1991